OPEN-ANGLE GLAUCOMA (OAG)
Clinical trials for OPEN-ANGLE GLAUCOMA (OAG) explained in plain language.
Never miss a new study
Get alerted when new OPEN-ANGLE GLAUCOMA (OAG) trials appear
Sign up with your email to follow new studies for OPEN-ANGLE GLAUCOMA (OAG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New laser technique could make glaucoma treatment easier
Disease control Recruiting nowThis study compares two FDA-approved laser treatments for open-angle glaucoma, a condition that damages the optic nerve due to high eye pressure. The goal is to see if a newer, non-contact laser (DSLT) works as well as the standard laser (SLT) in lowering eye pressure and prevent…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
New eye implant could give glaucoma patients a clearer future
Disease control Recruiting nowThis study tests a tiny drainage device called VisiPlate for people with open-angle glaucoma that hasn't responded to other treatments. The goal is to safely lower eye pressure by at least 20%. About 165 adults with high eye pressure will get the implant and be followed to see ho…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase: NA • Sponsor: Avisi Technologies Inc. • Aim: Disease control
Last updated May 17, 2026 08:00 UTC
-
Glaucoma showdown: which surgery cuts eye pressure best?
Disease control Recruiting nowThis study compares two procedures—iStent inject and Kahook Dual Blade goniotomy—done at the same time as cataract surgery in 100 adults with open-angle glaucoma. The goal is to see which approach better lowers eye pressure and reduces the need for daily eye drops. Participants m…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New eye drops aim to boost blood flow for diabetic retinopathy and glaucoma patients
Disease control Recruiting nowThis early study tests whether QLS-111 eye drops can improve blood flow in the back of the eye for people with diabetic retinopathy or certain types of glaucoma. About 14 participants will use the drops and have their eye blood flow measured over several weeks. The goal is to see…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New tool for glaucoma implant: easier insertion?
Disease control Recruiting nowThis study tests an updated inserter for a travoprost implant that is placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will take part to see if doctors can successfully use the new inserter as instructed. The goal …
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Sponsor: Glaukos Corporation • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New eye drug ER-100 enters first human safety trial
Symptom relief Recruiting nowThis early-stage study tests whether a single dose of ER-100 is safe for adults with open-angle glaucoma or NAION, two conditions that damage the optic nerve and can cause vision loss. Participants receive one dose and are monitored with eye exams, lab tests, and questionnaires f…
Matched conditions: OPEN-ANGLE GLAUCOMA (OAG)
Phase: PHASE1 • Sponsor: Life Biosciences Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:12 UTC